{
  "id": "ef3557e283e19764",
  "title": "Incyte Stock Drops Despite FDA Fast Track for Rare Cancer Drug",
  "description": "20251208T160000Z",
  "content": "",
  "source": "el-balad.com",
  "source_url": "https://www.el-balad.com/6789034",
  "published_at": "20251208T160000Z",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "Egypt",
  "raw_data": {
    "url": "https://www.el-balad.com/6789034",
    "url_mobile": "",
    "title": "Incyte Stock Drops Despite FDA Fast Track for Rare Cancer Drug",
    "seendate": "20251208T160000Z",
    "socialimage": "https://www.el-balad.com/uploads/images/202512/image_1200x675_6936ef036c29d.webp",
    "domain": "el-balad.com",
    "language": "English",
    "sourcecountry": "Egypt"
  }
}